- Are you up-to-date with the new Suboxone dosage form?
- Will your clients ask questions that you can’t answer?
- Do you have your own questions on the Suboxone Film?
Suboxone Film Live Webinar
Monday November 7 2011, 10.00am – 12noon
On September 1 2011, the new Suboxone Sublingual Film dosage form was listed on the Pharmaceutical Benefits Scheme (PBS) for opiate replacement therapy.
The new film addresses some of the treatment challenges of the Suboxone Sublingual Tablet including supervision time. Once placed under the tongue, the film adheres rapidly within 30-60 seconds forming a gel that is difficult to remove. This reduces supervision time and the potential for misuse.
The Suboxone Tablet will continue to be available and is PBS listed until 1/9/13.
Dr Sarz Maxwell, US addiction medical specialist (Medical Director, Chicago Recovery Alliance). Dr Maxwell graduated from Loyola Medical School in 1984, and completed her psychiatric training from 1984 through 1988, during the early years of the AIDS epidemic in Chicago. Dr Maxwell works with patients with many psychiatric and addiction problems, but her strongest interest is in heroin addicts. In 1998 Dr Maxwell became Medical Director of Chicago Recovery Alliance (CRA), a needle exchange and harm reduction outreach program. She helped CRA institute the world’s first naloxone distribution program which has saved more than 1,400 lives. Dr Maxwell sees patients in private practice, lectures and writes extensively about addiction, dual diagnosis, and harm reduction.
Dr Maxwell has been prescribing the Suboxone film since October 2010.
Dr Adrian Dunlop, Area Director, Drug and Alcohol Clinical Services for the Hunter New England Area Health Service in New South Wales and Conjoint Associate Professor in the School of Medicine and Public Health, Faculty of Health, University of Newcastle. He is a Foundation Fellow of the Chapter of Addiction Medicine (Chair of the NSW/ACT branch) and President of the Australasian Professional Society on Alcohol and other Drugs.
Peter Muhleisen, Pharmacist Hunter New England Health, Newcastle. Peter has a special interest and extensive experience in Addictions Pharmacotherapy. He was involved in multiple research projects at Turning Point in Melbourne looking at alternative Opioid Substitution Treatments to methadone. Peter writes regularly for pharmacy publications and co-authored guidelines and training materials. His current role has him involved in clinical work, research (including the Suboxone Film trial last year), training and consultancy.
There will also be opportunity for discussion with question and answer time.
Who should participate?
Harm reduction practitioners including nurses, GPs, pharmacists, NSP staff, education officers and workers within the drug and alcohol sector and peer groups.
How the webinar will take place?
Once you have registered, you will receive an email containing a direct link to the webinar, you will then need to enter your email address. From the comfort of your own desk you will see and hear the speakers and their presentations online.
This seminar is funded by Reckitt Benckiser. All content has been generated by Anex and/or speakers.